LUMACAFTOR + IVACAFTOR
lumacaftor 200 mg + ivacaftor 125 mg tablet, 112
LUMACAFTOR + IVACAFTOR (11466L)
11466L
Manner of administration:Oral
Restriction
Indication: Cystic fibrosis
Treatment phase: Initial treatment
Restriction
Indication: Cystic fibrosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 112 | # of repeats: 5 | DPMQ: $16,921.88 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Orkambi | |||||